Stratos Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.33M Buy
4,711
+924
+24% +$937K 0.27% 87
2025
Q4
$4.07M Buy
3,787
+40
+1% +$38.2K 0.2% 118
2025
Q3
$2.86M Buy
3,747
+168
+5% +$125K 0.14% 156
2025
Q2
$2.79M Sell
3,579
-20,363
-85% -$15.8M 0.15% 144
2025
Q1
$19.8M Buy
23,942
+19,972
+503% +$16.6M 1.08% 15
2024
Q4
$3.07M Sell
3,970
-591
-13% -$489K 0.15% 150
2024
Q3
$4.04M Sell
4,561
-21,951
-83% -$19.7M 0.19% 118
2024
Q2
$24M Sell
26,512
-122
-0.5% -$97.6K 1.19% 12
2024
Q1
$20.7M Buy
26,634
+21,406
+409% +$15.2M 1.23% 12
2023
Q4
$3.05M Buy
5,228
+329
+7% +$192K 0.18% 163
2023
Q3
$2.63M Sell
4,899
-256
-5% -$132K 0.17% 159
2023
Q2
$2.42M Buy
5,155
+47
+0.9% +$19.7K 0.17% 160
2023
Q1
$1.75M Sell
5,108
-631
-11% -$213K 0.14% 205
2022
Q4
$2.1M Buy
5,739
+481
+9% +$171K 0.18% 166
2022
Q3
$1.7M Sell
5,258
-147
-3% -$46.6K 0.18% 163
2022
Q2
$1.75M Buy
5,405
+579
+12% +$174K 0.16% 165
2022
Q1
$1.38M Buy
4,826
+960
+25% +$247K 0.11% 217
2021
Q4
$1.07M Buy
3,866
+290
+8% +$73.5K 0.08% 273
2021
Q3
$826K Sell
3,576
-705
-16% -$174K 0.07% 282
2021
Q2
$983K Buy
4,281
+1,938
+83% +$389K 0.09% 241
2021
Q1
$438K Buy
2,343
+972
+71% +$190K 0.05% 331
2020
Q4
$232K Buy
+1,371
New +$205K 0.03% 360
2019
Q4
Sell
-2,645
Closed -$296K 208
2019
Q3
$296K Sell
2,645
-189
-7% -$21K 0.11% 185
2019
Q2
$314K Sell
2,834
-44
-2% -$5.18K 0.13% 170
2019
Q1
$373K Sell
2,878
-17
-0.6% -$2.07K 0.2% 132
2018
Q4
$335K Buy
+2,895
New +$323K 0.22% 128

Other funds holding LLY

Stratos Wealth Advisors's LLY Position: Q1 2026 in Review

Stratos Wealth Advisors increased its Eli Lilly (LLY) stake by 24% in Q1 2026, buying an estimated $937K and bringing the position to 4,711 shares worth $4.33M. The position accounts for 0.27% of the portfolio, ranked #87.

Stratos Wealth Advisors first reported a position in LLY in Q4 2018 and has held it in 26 quarters since. The position peaked at $24M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Stratos Wealth Advisors held 4,711 shares of Eli Lilly worth $4.33M as of Q1 2026.
  • Stratos Wealth Advisors bought 924 Eli Lilly shares in Q1 2026, an estimated $937K.
  • Eli Lilly made up 0.27% of Stratos Wealth Advisors's portfolio in Q1 2026, its #87 holding.
  • Stratos Wealth Advisors first reported a position in Eli Lilly in Q4 2018 and has held it in 26 quarters since.
  • Stratos Wealth Advisors's Eli Lilly position peaked at $24M in Q2 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Stratos Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.